May 09,2022

OncoHealth Secures Strategic Investments from Arsenal Capital Partners & McKesson Corporation

OncoHealth, the leading digital health company dedicated to oncology, announced today it has received strategic investments from Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in building transformational healthcare businesses, and from McKesson Corporation (“McKesson”). The investments will support OncoHealth’s innovation and delivery of its oncology-specific digital health solutions for people with cancer, and Arsenal will take a majority ownership stake in the business. Additional financial terms of the transaction were not disclosed.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
May 04,2022

Sidekick Health grabs $55M for digital-first care programs

Iceland’s Sidekick Health has developed a gamified digital care platform that’s designed to support healthcare outcomes by applying personalized behavioral lifestyle nudges, including alongside clinical treatments like drugs, to augment, extend and support patient care for a range of chronic diseases and conditions from cancer to cardiovascular health, diabetes and arthritis — a formula that’s now scored it $55 million in Series B growth funding. The new round is led by London-based VC firm Novator Ventures, with participation from Wellington Partners, Asabys Partners and Frumtak Ventures, as well as a U.S.-based strategic investor which it’s not disclosing yet but says will be revealed at a later stage.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
May 09,2022

Oncological digital therapeutics company Fosanis raises more than $10.5M

Fosanis announced today that it closed a Series A funding round worth more than $10.5 million (€10 million). Berlin, Germany-based Fosanis, which develops prescription digital therapeutics for all oncological indications, picked up investments from existing shareholder Ananada Impact Ventures, as well as new investors Debiopharm Innovation Fund, Ship2B Ventures and Equity Pitcher.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 19,2022

OncoRes Medical raises another $12.5M

OncoRes Medical announced that it raised $12.5 million for its handheld imaging device for identifying cancer cells. Perth, Western Australia-based OncoRes designed its imaging system to facilitate real-time tumor assessment, helping surgeons more accurately identify and remove cancerous tissue, including for breast cancer.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
May 13,2022

AI-Powered oncology platform raises $35 million Series C funding round

OncoHost has announced a Series C $35 million funding round led by ALIVE Israel HealthTech VC, as well as other prominent investors. The funding will go towards expanding OncoHost’s ongoing multicenter PROPHETIC trial (Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments) as well as support its upcoming US commercial launch.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Jun 03,2022

Massive Bio Raises $9 Million To Scale Growth and Fuel Global Expansion of AI-Enabled Oncology Clinical Trial Platform

Massive Bio, Inc., a leader in precision medicine and artificial intelligence (AI) enabled patient-centric clinical trial enrollment, raised $9 million co-led by Revo Capital and Kenan Turnacıoğlu, with additional participation from DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH, the German Development Finance Institution. This investment will enable the company to further scale its operations globally, invest in marketing, and launch additional non-status quo products in oncology clinical trial enrollment with its data-rich platform.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jul 06,2022

RefleXion closes $125M debt facility

Biology-guided radiotherapy (BgRT) technology developer RefleXion Medical announced today that it closed a $125 million debt facility. Hayward, California–based RefleXion has $55 million of the $125 million total available immediately to repay its existing $50 million in debt. The remaining $70 million will be made available upon the achievement of certain regulatory and commercial milestones.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Aug 04,2022

Atropos Health Announces $14M Series A, Taps Co-founder as CEO

Hyde served as a healthcare partner at the AI venture fund Symphony AI, where he led the investment in, co-founded, and operated Concert AI, an oncology RWD company – most recently valued at $1.9B. "I am excited about the enormous potential Atropos has to advance

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 25,2022 TOP STORY

COTA Announces New Financing from Deerfield Management and Prior Investors To Accelerate Cancer Research and Treatment Innovation

COTA, Inc., an oncology real-world data and analytics company, announced its latest financing by an investment fund managed by Deerfield Management, a healthcare investment firm. Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. In conjunction, COTA announced it has raised additional capital from existing investors. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

FUNDING SERIES E
View Analyst & Ambassador Comments
Go to original news
Jan 15,2021

AI cancer pathology developer Paige nets $100M

After scoring two European approvals last month for its artificial-intelligence-powered cancer pathology platforms, Paige has secured $100 million in new funding to boost its development of biomarkers as clinical applications. The New York-based company’s series C round was led by Casdin Capital and Johnson & Johnson Innovation, the drugmaker’s strategic venture capital arm.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING